World Pain Relieving Drug Market 2012-2022

Visiongain
August 8, 2012
235 Pages - SKU: VSG4881895
Generalized Seizures Global Clinical Trials Review, H2, 2014
7/14/2014 | published by: GlobalData
Generalized Seizures Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Generalized Seizures Global Clinical Trials Review, H2, 2014 provides data on the Generalized Seizures clinical trial scenario. This report provides elemental information and data  |  read more...
USD 2,500
Insomnia Global Clinical Trials Review, H2, 2014
7/14/2014 | published by: GlobalData
Insomnia Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Insomnia Global Clinical Trials Review, H2, 2014 provides data on the Insomnia clinical trial scenario. This report provides elemental information and data relating to the  |  read more...
USD 2,500
Pharmaceuticals and Healthcare Report - Malaysia - Q3 2014
7/23/2014 | published by: Business Monitor International
Malaysia Pharmaceuticals and Healthcare Report Q3 2014 BMI View: We remain generally optimistic towards Malaysia's commitment to provide better quality andaccess to healthcare, as the government plans to expand and upgrade its hospital network. However, wehave  |  read more...
USD 1,295
Proteins in Oncology Drug Pipeline Update 2014
7/15/2014 | published by: BioSeeker Group AB
Proteins in Oncology Drug Pipeline Update 2014 This drug pipeline update covers proteins, excluding antibodies, as drugs for the treatment of cancer. There are today 326 companies plus partners developing 359 protein drugs in 667 developmental projects  |  read more...
USD 6,746
Follicular Lymphoma - Pipeline Review, H2 2014
7/15/2014 | published by: Global Markets Direct
Follicular Lymphoma - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Follicular Lymphoma - Pipeline Review, H2 2014’, provides an overview of the Follicular Lymphoma’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Follicular  |  read more...
USD 2,000
Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) - Pipeline Review, H2 2014
7/15/2014 | published by: Global Markets Direct
Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) - Pipeline Review, H2 2014’, provides an overview of the Peripheral Arterial  |  read more...
USD 2,000
Malignant Mesothelioma - Pipeline Review, H2 2014
7/15/2014 | published by: Global Markets Direct
Malignant Mesothelioma - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Malignant Mesothelioma - Pipeline Review, H2 2014’, provides an overview of the Malignant Mesothelioma’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Malignant  |  read more...
USD 2,000
Myocardial Infarction - Pipeline Review, H2 2014
7/15/2014 | published by: Global Markets Direct
Myocardial Infarction - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Myocardial Infarction - Pipeline Review, H2 2014’, provides an overview of the Myocardial Infarction’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Myocardial  |  read more...
USD 2,000
Bone Marrow Transplantation - Pipeline Review, H2 2014
7/15/2014 | published by: Global Markets Direct
Bone Marrow Transplantation - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Bone Marrow Transplantation - Pipeline Review, H2 2014’, provides an overview of the Bone Marrow Transplantation’s therapeutic pipeline. This report provides comprehensive information on the therapeutic  |  read more...
USD 2,000
Familial Hypercholesterolemia (Type II Hyperlipoproteinemia) - Pipeline Review, H2 2014
7/15/2014 | published by: Global Markets Direct
Familial Hypercholesterolemia (Type II Hyperlipoproteinemia) - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Familial Hypercholesterolemia (Type II Hyperlipoproteinemia) - Pipeline Review, H2 2014’, provides an overview of the Familial Hypercholesterolemia (Type II Hyperlipoproteinemia)’s therapeutic pipeline. This report  |  read more...
USD 2,000
 

SELECT A LICENSE

    Electronic Access
Single User Fulfilled By Publisher
  USD 2,820  
    Electronic Access
Departmental 1-5 Users
  USD 4,978  
    Electronic Access
Global Site License Fulfilled By Publisher
  USD 11,618  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!